NANOREPRO
DEAD

Serial Number

97247706

Owner

LOGIQ, INC.

Attorney

Jeffrey Joyce

Filing Date

Feb 1, 2022

Add to watchlist:

No watchlists yet
View on USPTO

NANOREPRO Trademark

Serial Number: 97247706

NANOREPRO is a trademark filed by LOGIQ, INC. on February 1, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 11 (Environmental Control), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

LOGIQ, INC. (10 trademarks)

NEW YORK, NY 10004

Entity Type: 03

Trademark Details

Filing Date

February 1, 2022

Registration Date

Not Registered

Published for Opposition

September 5, 2023

Goods & Services

Cryopreservation of human tissue, particularly cells and adult stem cells; technical consulting in the field of cryopreservation

pharmaceutical preparations and products for healthcare namely SARS-CoV-2 Antigen Rapid Test kits comprised of medical diagnostic test strips, swabs for medical purposes and fluid collection vials for detecting the presence of a virus; pharmaceutical preparations and products for healthcare namely medical diagnostic test kits comprised of medical diagnostic reagents for use in detecting the presence of microorganisms, infectious agents, antibodies, antigens, receptors and contaminants in humans and animals for diagnostic medical use; diagnostic preparations for medical purposes; in vitro diagnostic preparations for medical purposes; medical diagnostic test paper strips for the qualitative detection of SARS-CoV-2 viral nucleocapsid antigens from anterior nasal secretion; medical diagnostic test paper strips for detecting pregnancy and ovulation; biological preparations for medical purposes for the treatment of SARS-CoV-2; chemical preparations for medical purposes for the treatment of SARS-CoV-2; chemical reagents for medical purposes; hormones for medical purposes; diagnostic reagents for detecting SARS-CoV-2 Antigen; monoclonal antibodies for detecting SARS-CoV-2 Antigen

providing business information; providing an online marketplace for buyers and sellers of goods and services; procurement services for third parties, namely, purchasing goods and services namely medical diagnostic reagent test strips, swabs for medical purposes and fluid collection vials for other businesses providing in vitro medical diagnostic test kits, for professional medical or consumer use, for monitoring conditions or diagnosing; import-export agency services; retail store services featuring In vitro medical diagnostic test kits, for professional medical or consumer use, consisting of reagent test strips, reagents and test equipment for monitoring conditions or diagnosing disease; wholesale store services featuring in vitro medical diagnostic test kits, for professional medical or consumer use, consisting of reagent test strips, reagents and test equipment for monitoring conditions or diagnosing disease; advertising copywriting; marketing services; market intelligence services; on-line retail store services featuring in vitro medical diagnostic test kits, for professional medical or consumer use, consisting of reagent test strips, reagents and test equipment for monitoring conditions or diagnosing disease; online wholesale store services featuring in vitro medical diagnostic test kits, for professional medical or consumer use, consisting of reagent test strips, reagents and test equipment for monitoring conditions or diagnosing disease; organization of exhibitions and fairs for commercial and promotional purposes; sales promotion for third parties; advertising; targeted marketing services

Air cooling apparatus; cooling apparatus for cryopreservation namely cryogenic freezers and cryorefrigerators

scientific research; scientific analysis in the field of detecting the presence of microorganisms, infectious agents, antibodies, antigens, receptors and contaminants in humans and animals for diagnostic medical use; chemical analyses; scientific and technological services, namely scientific research and testing in the field of SARS-Cov-2 and infectious diseases; scientific laboratory services for technical measurement and testing; biochemical research; stem cell research services; biological research; chemical research; chemistry services namely chemistry consultation; development of pharmaceutical diagnostic tests and rapid diagnostic tests

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 12, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 3, 2024 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 31, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 5, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 5, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 16, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 3, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 2, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 2, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 2, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 2, 2023 GNFN
FINAL REFUSAL E-MAILED
Jun 2, 2023 GNFR
FINAL REFUSAL WRITTEN
Jun 2, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 21, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 21, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 21, 2022 GNRN
NON-FINAL ACTION E-MAILED
Nov 21, 2022 GNRT
NON-FINAL ACTION WRITTEN
Nov 21, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 14, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 7, 2022 NWOS
NEW APPLICATION ENTERED
Feb 4, 2022 NWAP